TRIM38 autoantibodies, a Ro52-related molecule, were present in 30% of the non-ILD SjD cohort, 20% of the SjD-ILD cohort, and 5% of IIM-ILD patients (Figure 3C). The gene discussed is TRIM21; the disease is acquired idiopathic inflammatory myopathy.